0
Upcoming Allied Market Research
2023
Neuroprotective Products Market

Neuroprotective Products Market

Size, Share, Competitive Landscape and Trend Analysis Report by Class of Drugs (Cholinesterase inhibitors, NMDA receptor antagonists, Anti-inflammatory and anti-apoptotic agents, Neurotropic factors, Mitochondrial dysfunction regulators, Metal Ion Chelators, Ion channel modulators, Ion channel modulators, Free radical trappers, Anti excitotoxic agents, Others) and by use in the treatment of Medical Conditions (Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Ocular degeneration (retinal disorders), Amyotrophic lateral sclerosis (ALS), Huntington's disease, Neuropathies, Brain injury, Other disorders affecting the nervous system.): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A00172
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others. Neurodegenerative diseases and their prevalence increases significantly with age. Hence, the demand for neuroprotectives would increase in the future, as average life spans are increasing, which opens up a huge market for novel drugs for the treatment of these diseases. The drivers for this market are the increasing incidence and prevalence of neurodegenerative diseases, especially in aging populations and a need for the treatment of brain injuries caused chiefly by road accidents. However, high costs involved in research and development, strict regulatory approvals and the high failure rate of majority of the prospective drugs in clinical trials would restrict growth in this market. With the high prevalence rates of neurogenerative disease and the lack of specific treatment options, the opportunities are tremendous for the entry of novel drugs.

Neuroprotective Products Market by Class of Drugs

The neuroprotective drugs are Cholinesterase inhibitors, NMDA receptor antagonists, Ion channel modulators, Anti-inflammatory and anti-apoptotic agents, Mitochondrial dysfunction regulators Neurotropic factors, Anti excitotoxic agents , Ion channel modulators, Metal Ion Chelators Free radical trappers, and others. 
The Cholinesterase inhibitors and NMDA receptor antagonists are used to treat Alzheimers. As the disease burden is high for this ailment, these drugs would command a major market share. However, the opportunity for emerging drugs is high, as CNS disorders involve an interplay of highly complex and multi- factorial processes & pathways.  Therefore, investment in research and development would have high pay offs.

Neuroprotective Products Market by use in the treatment of Medical Conditions

The neuroprotective drugs are used in the treatment of Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Brain injury, Huntington's disease, Retinal disorders, Amyotrophic lateral sclerosis (ALS), Neuropathies, and other disorders affecting the nervous system.
According to the Alzheimer's association, an estimated 5.2 million Americans have Alzheimer's and it is the 6th leading cause of death accounting for the death of more than 500,000 persons per year in the United States. Hence, the market for treatment of Alzheimers is huge and it would spur the development of neuroprotective drugs.

Neuroprotective Market by Geography

The market is segmented by geography into North America, Europe, Asia Pacific and RoW. In the United States, death due to Alzheimers increased by 68 percent during 2000 to 2010. According to the Parkinson Disease foundation, 60,000 Americans are diagnosed of Parkinsons each year. Hence, North America is the major market for these products. World –wide, an estimated five to seven million people are living with Parkinson disease, which would increase the demand for neuroprotective drugs and spur research and development. Europe and Asia Pacific would also see an increased demand as the cases for neurodegenerative diseases increases in these regions.

Competitive Analysis

Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals, Allon therapeutics, Inc., Bionure Inc. are some of the key players in this market. In 2013, Bionure and The Myelin Repair Foundation (MRF) entered into a collaborative partnership agreement with the aim of advancing development of therapeutics for multiple sclerosis. This partnership would enable the commercialization of many promising compounds for the treatment of multiple sclerosis.

High Level Analysis

An overview of the neuroprotective market by segmentation of the market by type, application and geography, identifies the opportunities as well as associated risks in this market. Porter’s five force model analyzes the bargaining power of the supplier and buyer  as well as the threat posed by substitutes and new entrants which would enable a deeper understanding of changing market dynamics. The report helps to identify market leaders and the strategic business decisions taken by them. The impact of drivers, restraints and opportunities and other market dynamics are described in detail.

KEY BENEFITS

  • Competitive analysis of companies and policies adopted by competitors  would help in making strategic decisions
  • In-depth analysis of current market scenario would help in understanding opportunities in this market
  • Segmentation based on applications would help in understanding future growth prospects and areas where investments can be made.
  • Analysis of drivers and restrains focuses on the opportunities and risks of this market, which would enable decision-making
  • Estimations of growth in this market based on upcoming drugs would give an overall idea of areas of growth to stakeholders. 

Neuroprotective Products Market Report Highlights

Aspects Details
By Class of Drugs
  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Anti-inflammatory and anti-apoptotic agents
  • Neurotropic factors
  • Mitochondrial dysfunction regulators
  • Metal Ion Chelators
  • Ion channel modulators
  • Ion channel modulators
  • Free radical trappers
  • Anti excitotoxic agents
  • Others
By use in the treatment of Medical Conditions
  • Alzheimer's disease
  • Multiple sclerosis
  • Parkinson's disease
  • Ocular degeneration (retinal disorders)
  • Amyotrophic lateral sclerosis (ALS)
  • Huntington's disease
  • Neuropathies
  • Brain injury
  • Other disorders affecting the nervous system.
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
Key Market Players Merck & Co., Inc., Teva Pharmaceuticals, UCB S.A., Athersys Inc., Novartis AG, Pfizer Inc., Biogen Inc., Avanir Pharmaceuticals Inc., GlaxoSmithKline plc, Baxter International Inc.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Neuroprotective Products Market

Start reading.
This Report and over 71,296+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers